Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103153 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos
A NA study of Unwanted Tattoos, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT02103153: Completed NA study of Unwanted Tattoos, sponsored by Cynosure.
NCT02103153 is a NA study of Unwanted Tattoos that has completed, run by Cynosure. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02103153, a NA study of Unwanted Tattoos, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the PICOSURE Laser System for the treatment of unwanted tattoos
Primary Outcome
Clearance will be measured using a clearance aesthetic improvement scale. This scale ranges from 0% to 100%, where 0% is 0% tattoo cleared compared to the baseline tattoo, and 100% is 100% of tattoo cleared compared to the baseline tattoo.
Conditions Studied
Interventions
- DEVICE Picosure Laser System
Study Locations (1)
New York
- Laser & Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02103153 record still lists
NCT02103153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Unwanted Tattoos appearing as the primary indexed condition, and to 1 intervention - of which Picosure Laser System is the first listed.
NCT02103153 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02103153 about?
NCT02103153 is a clinical study titled "Clinical Evaluation of the Picosure Laser for the Treatment of Unwanted Tattoos". The purpose of this study is to evaluate the PICOSURE Laser System for the treatment of unwanted tattoos
What is the current status of trial NCT02103153?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2013-09. Estimated completion is 2017-01.
What conditions does trial NCT02103153 study?
This clinical trial studies the following conditions: Unwanted Tattoos.
What interventions are being tested in trial NCT02103153?
The interventions under investigation include: Picosure Laser System (DEVICE).
Who is sponsoring clinical trial NCT02103153?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02103153 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unwanted Tattoos
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02103153's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia